-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENXBIO INC - FAVORABLE SAFETY PROFILE CONTINUES WITH NO SERIOUS ADVERSE EVENTS OBSERVED IN RGX-202 TRIAL

Reuters·06/05/2025 11:05:03

Please log in to view news